ESOPMay 13, 2026, 04:09 PM
Ascendis Pharma Grants 31,250 Warrants to Employees at $237.65
AI Summary
Ascendis Pharma A/S announced that its board of directors granted an aggregate of 31,250 warrants to certain employees on May 12, 2026. Each warrant allows the holder to subscribe for one ordinary share at an exercise price of US $237.65, which was the closing price on the grant date. The warrants will vest over time, with 25% vesting on the one-year anniversary and the remaining 75% vesting monthly thereafter, contingent on continued service. Following this grant, 1,580,593 shares remain available for future warrant grants.
Key Highlights
- Ascendis Pharma's board granted 31,250 warrants to employees on May 12, 2026.
- Each warrant confers the right to subscribe for one ordinary share of the Company.
- The exercise price is US $237.65 per share, based on the closing price on the grant date.
- 25% of the warrants will vest on the one-year anniversary of the grant date.
- The remaining 75% will vest at a rate of 1/36th per month from one year after grant.
- Vesting is subject to continued employee service.
- After this grant, 1,580,593 shares remain available for future warrant grants.
- The Company amended its Articles of Association to provide for these warrants.
Price Impact
More from ASND